Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

Blood. 2017 Jun 22;129(25):3389-3391. doi: 10.1182/blood-2016-11-751719. Epub 2017 May 3.

Leendert Porcelijn¹, Elly Huiskes¹, Martin Schipperus², Bronno van der Holt³, Masja de Haas^{1

4

5

6}, Jaap Jan Zwaginga^{5

6}; Dutch HOVON 64 Study Group

¹ Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, The Netherlands.
² Department of Internal Medicine, HagaZiekenhuis, Den Haag, The Netherlands.
³ Haemato Oncology Foundation for Adults in The Netherlands (HOVON) Data Center, Erasmus MC Cancer Institute-Clinical Trial Centre, Rotterdam, The Netherlands.
⁴ Sanquin Research and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
⁵ Center for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands; and.
⁶ Department of Immuno-hematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.

No abstract available

Publication types